Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study aimed to evaluate antibody responses induced by the BBIBP‐CorV vaccine in pregnant women and investigate its association with serum vitamin D levels.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This cross‐sectional study was conducted from August 2021 to April 2022 in Ilam, western Iran.
Source: Methods.
Participants were explicitly informed during the informed consent process about blood sample collection and the potential future use of their biological samples and research data.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D Level and Antibody Response to the BBIBP‐CorV Vaccine in Pregnant Women
Cross-sectional study · Journal of Tropical Medicine · 2026
Original publication title
Vitamin D Level and Antibody Response to the BBIBP‐CorV Vaccine in Pregnant Women
Copyright © 2026 Shahab Falahi et al. Journal of Tropical Medicine published by John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Background and Aims
Several factors influence the response to the vaccine, including age, gender, pregnancy, microbiota composition, immune function, sex hormones, and micronutrients (such as vitamin D). This study aimed to evaluate antibody responses induced by the BBIBP‐CorV vaccine in pregnant women and investigate its association with serum vitamin D levels.
Source: Background and AimsAbstract: What methods does the paper describe?
Serum samples were collected from 140 pregnant women 1 to 2 months after administering the second dose of the BBIBP‐CorV vaccine from August 2021 to April 2022. IgG antibody titers against RBD and serum vitamin D levels were measured using enzyme‐linked immunosorbent assay (ELISA). The relationship between vitamin D levels and anti‐RBD IgG antibody titer was investigated with linear regression analysis.
Source: MethodsAbstract: Results
Anti‐RBD IgG antibodies were detected in 17% (24 out of 140) of the population studied. A positive correlation was observed between serum vitamin D level and anti‐RBD IgG antibody titer (p < 0.001).
Source: ResultsAbstract: Conclusion
Our study showed that two doses of the BBIBP‐CorV vaccine elicited antibody responses against COVID‐19 in only a small proportion of pregnant women, suggesting that higher doses or alternative vaccine platforms may be required to protect pregnant women. Despite the existence of a relationship between vitamin D levels and antibody response in our study, prospective clinical trial studies are needed to draw definitive conclusions regarding the effect of vitamin D on antibody response.
Source: ConclusionAuthors’ abstract
Background and Aims
Several factors influence the response to the vaccine, including age, gender, pregnancy, microbiota composition, immune function, sex hormones, and micronutrients (such as vitamin D). This study aimed to evaluate antibody responses induced by the BBIBP‐CorV vaccine in pregnant women and investigate its association with serum vitamin D levels.
Methods
Serum samples were collected from 140 pregnant women 1 to 2 months after administering the second dose of the BBIBP‐CorV vaccine from August 2021 to April 2022. IgG antibody titers against RBD and serum vitamin D levels were measured using enzyme‐linked immunosorbent assay (ELISA). The relationship between vitamin D levels and anti‐RBD IgG antibody titer was investigated with linear regression analysis.
Results
Anti‐RBD IgG antibodies were detected in 17% (24 out of 140) of the population studied. A positive correlation was observed between serum vitamin D level and anti‐RBD IgG antibody titer (p < 0.001).
Conclusion
Our study showed that two doses of the BBIBP‐CorV vaccine elicited antibody responses against COVID‐19 in only a small proportion of pregnant women, suggesting that higher doses or alternative vaccine platforms may be required to protect pregnant women. Despite the existence of a relationship between vitamin D levels and antibody response in our study, prospective clinical trial studies are needed to draw definitive conclusions regarding the effect of vitamin D on antibody response.
Publication and source details
Original title: Vitamin D Level and Antibody Response to the BBIBP‐CorV Vaccine in Pregnant Women
Shahab Falahi; Mahdi Vahabi; Hojjat Sayyadi; Azra Kenarkoohi
Journal of Tropical Medicine · 2026
Copyright © 2026 Shahab Falahi et al. Journal of Tropical Medicine published by John Wiley & Sons Ltd.2026https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the https://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Ilam University of Medical Sciences10.13039/501100003841 14021004/15Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-08T11:17:59+00:00
DOI: 10.1155/jotm/1649421 · PMC13563054